Adsorption of complement, cytokines, and proteins by different dialysis membrane materials: Evaluation by confocal laser scanning fluorescence microscopy

被引:49
作者
Fujimori, A [1 ]
Naito, H [1 ]
Miyazaki, T [1 ]
机构
[1] Konan Hosp, Dept Artificial Kidney, Higashinada Ku, Kobe 658, Japan
关键词
confocal laser scanning fluorescence microscopy; dialysis membrane; biocompatibility; cytokine; C3a; adsorption;
D O I
10.1046/j.1525-1594.1998.06083.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The membranes tested in the present study were cellulose triacetate (CTA), polymethylmethacrylate (PMMA), and polyacrylonitrile (PAN). The adsorption by each membrane of albumin, IgG, C3a, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), human neutrophil elastase (HNE), and tumor necrosis factor alpha (TNF alpha) was examined and semiquantitatively graded by confocal laser scanning fluorescence microscopy (CLSFM). After clinical use the dialyzers were treated with antibodies for these proteins and cytokines. Then the samples were incubated with fluorescein isothiocyanate-labeled anti-IgG antibody and observed by CLSFM. The changes in the blood levels of C3a and cytokines were also studied. In the CTA membrane, the adsorption of these substances, except for albumin and HNE, was less than in the synthetic membranes. The PAN membrane revealed the most abundant adsorption, especially for IL-1 beta, IL-6, and TNF alpha. Although a marked elevation of C3a in the blood was-observed in the CTA membrane, considerable adsorption was evident in the PMMA and the PAN membranes. Because the changes in the blood levels could be affected by membrane adsorption, both the blood levels and the adsorption of the biocompatibility parameters should be evaluated when membrane biocompatibility is discussed.
引用
收藏
页码:1014 / 1017
页数:4
相关论文
共 8 条
[1]  
AKIZAWA T, 1986, PROGR ARTIFICIAL ORG, P1169
[2]   ANAPHYLATOXIN FORMATION DURING HEMODIALYSIS - EFFECTS OF DIFFERENT DIALYZER MEMBRANES [J].
CHENOWETH, DE ;
CHEUNG, AK ;
HENDERSON, LW .
KIDNEY INTERNATIONAL, 1983, 24 (06) :764-769
[3]  
CHOLLETMARTIN S, 1991, CLIN EXP IMMUNOL, V83, P329
[4]   HEMODIALYSIS-ASSOCIATED PLATELET ACTIVATION AND THROMBOCYTOPENIA [J].
HAKIM, RM ;
SCHAFER, AI .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (04) :575-580
[5]   BIOCOMPATIBILITY OF DIALYSIS MEMBRANES - EFFECTS OF CHRONIC COMPLEMENT ACTIVATION [J].
HAKIM, RM ;
FEARON, DT ;
LAZARUS, JM .
KIDNEY INTERNATIONAL, 1984, 26 (02) :194-200
[6]   CLINICAL IMPLICATIONS OF HEMODIALYSIS MEMBRANE BIOCOMPATIBILITY [J].
HAKIM, RM .
KIDNEY INTERNATIONAL, 1993, 44 (03) :484-494
[7]   BIOCOMPATIBILITY OF HIGH-FLUX MEMBRANES [J].
PUTZ, D ;
BARNAS, U ;
LUGER, A ;
MAYER, G ;
WOLOSZCZUK, W ;
GRAF, H .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1992, 15 (08) :456-460
[8]   COMPARISON OF BLOOD BIOCOMPATIBILITY DURING HEMODIALYSIS WITH CUPROPHANE AND POLYACRYLONITRILE MEMBRANES [J].
SEYFERT, UT ;
HELMLING, E ;
HAUCK, W ;
SKROCH, D ;
ALBERT, W .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1991, 6 (06) :428-434